In Vivo panCAR™ Therapy for the Treatment of Autoimmune Disease

This webinar introduces Orna Therapeutics’ panCAR™ platform, which combines a synthetic, circular coding RNA (oRNA®) and proprietary immunotropic lipid nanoparticles (LNPs) to drive CAR expression on the surface of immune effector cells.

Publish Date: November 24, 2025

See other videos & webinars

Webinar: In Vivo panCAR™ Therapy for the Treatment of Autoimmune Disease

To view the webinar, please complete the form, or sign in to your account.

I agree to receive future electronic communications from ��ƽ��. I acknowledge that I can unsubscribe at any time.

By submitting this form, you are providing your consent to ��ƽ�� Technologies Canada Inc. and its subsidiaries and affiliates (“��ƽ��”) to collect and use your information, and send you newsletters and emails in accordance with our privacy policy. Please contact us with any questions that you may have. You can unsubscribe or change your email preferences at any time.

Request Pricing

Thank you for your interest in this product. Please provide us with your contact information and your local representative will contact you with a customized quote. Where appropriate, they can also assist you with a(n):

Estimated delivery time for your area

Product sample or exclusive offer

In-lab demonstration